PharmiWeb.com - Global Pharma News & Resources
PharmiWeb Today Story
ISPE Names Eli Lilly Kinsale Limited the 2024 Facility of the Year Awards Overall Winner

Prestigious award honors top pharmaceutical facility projects each year; showcases impressive engineering feats and technological innovation

NORTH BETHESDA, Md., Oct. 14, 2024 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) has recognized Eli Lilly Kinsale Limited as the Overall Winner of the 2024 Facility of the Year Awards (FOYA) for its IE2b facility based in Kinsale, Ireland. The winner was announced and formally recognized during ISPE's FOYA Banquet and Awards Celebration held in conjunction with the 2024 ISPE Annual Meeting & Expo in Orlando, Florida. The vision for Eli Lilly's IE2b project was to marry innovative, advanced technologies into a first-of-its-kind hybrid manufacturing platform in order to optimize synthetic peptide production for use in life-saving medications.

Eli Lilly's IE2b was recognized as a winner in the 2024 FOYA Innovation Category for its hybrid manufacturing platform. The novel platform uses solid phase synthesis of small, high-purity peptide fragments with efficient liquid phase peptide bond-forming chemistry and leverages continuous processing technology and principles. Process analytical technology, a cutting-edge nanofiltration system, and a digital material tracking model all helped the facility significantly boost annual throughput while minimizing risk, and inefficiency– all to produce high-volume, complex peptides at a commercial manufacturing scale.

The Lilly IE2b facility underscores the importance of perseverance of innovation through adversity. The build s…

Read More...
ISPE Names Eli Lilly Kinsale Limited the 2024 Facility of the Year Awards Overall Winner

Articles